| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/22/2004 | EP1458709A1 New process |
| 09/22/2004 | EP1458708A2 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458707A2 New compounds |
| 09/22/2004 | EP1458706A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 09/22/2004 | EP1458688A1 Quinazolinone derivative |
| 09/22/2004 | EP1458687A2 Pyrimidine compounds |
| 09/22/2004 | EP1458685A2 Substituted phenyl derivatives |
| 09/22/2004 | EP1458684A2 Therapeutic heterocycles |
| 09/22/2004 | EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 09/22/2004 | EP1458682A1 1,4-dihydro-1,4-diphenylpyridine derivatives |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458413A2 Pharmaceutical compositions based on azetidine derivatives |
| 09/22/2004 | EP1458393A1 Substituted diketopiperazines as oxytocin antagonists |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 09/22/2004 | EP1458385A2 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458383A2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458380A1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1169320B1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 09/22/2004 | EP1157989B1 Fluorides of 4-substituted piperidine derivatives |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1140860B1 Pyrimidine compounds |
| 09/22/2004 | EP1100781B1 High affinity ligands for nociceptin receptor orl-1 |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP1012164B1 Serine protease inhibitors |
| 09/22/2004 | EP0914321B1 Indole derivatives for the treatment of osteoporosis |
| 09/22/2004 | CN1531534A 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and use thereof as pesticides |
| 09/22/2004 | CN1531533A Crystalline form of omeprazole |
| 09/22/2004 | CN1531532A Method for separating methyl 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro- 2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrimidine-carboxylate-racemate |
| 09/22/2004 | CN1531531A Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531527A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |
| 09/22/2004 | CN1531432A New use of iloperidone |
| 09/22/2004 | CN1167785C Bleaching composition and method for bleaching sustrate |
| 09/22/2004 | CN1167698C New N-triazolyl methyl piperazine derivative using as neurokinin receptor antagonistic agent |
| 09/22/2004 | CN1167687C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 09/22/2004 | CN1167686C Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds |
| 09/22/2004 | CN1167682C Muscarinic antagonists |
| 09/22/2004 | CN1167680C Fused-ring compounds and use thereof as drugs |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/21/2004 | US6794518 Vitronectin receptor antagonist pharmaceuticals |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794511 An enzyme inhibitors of metalloprotease; treating connective tissue degradation caused by inflammation or tumor |
| 09/21/2004 | US6794507 Compounds that inhibit factor Xa activity |
| 09/21/2004 | US6794506 Treatment of inflammatory diseases, such as asthma, alzheimer's disease, atherosclerosis, aids dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis |
| 09/21/2004 | US6794404 Viral polymerase inhibitors |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794395 Substituted indolinones, their manufacture and their use as medicaments |
| 09/21/2004 | US6794393 Tyrosine kinase inhibitors |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
| 09/21/2004 | US6794381 Succinoylamino lactams as inhibitors of aβ protein |
| 09/21/2004 | US6794380 Amide derivatives |
| 09/21/2004 | US6794379 Antiinflammatory agents; autoimmune disease; skin disorders |
| 09/21/2004 | US6794377 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, useful for the treatment and prophylaxis of atrial arrhymias, e.g. atrail fibrillation or atrial flutters |
| 09/21/2004 | US6794336 Herbicidal substituted pyridines, their preparation, and their use as herbicides and plant growth regulators |
| 09/21/2004 | CA2200316C Imidazole derivative |
| 09/21/2004 | CA2191871C Piperazine derivatives as 5ht1a antagonists |
| 09/21/2004 | CA2114017C Amide tetrazole acat inhibitors |
| 09/21/2004 | CA2076226C Substituted 1-pyrimidinylacetamide compounds |
| 09/21/2004 | CA2033143C Alkyl esters of 5-heterocyclic-pyridine-2,3-dicarboxylate acids, 5-heterocyclic 2-(2-imidazoline-2-yl)pyridines, useful as herbicidal agents and methods for the preparation thereof |
| 09/16/2004 | WO2004078752A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 09/16/2004 | WO2004078749A1 Heterocyclic urea derivatives for the treatment of pain |
| 09/16/2004 | WO2004078748A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078747A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078746A2 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders |
| 09/16/2004 | WO2004078745A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 09/16/2004 | WO2004078744A2 Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain |
| 09/16/2004 | WO2004078743A1 Substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof |
| 09/16/2004 | WO2004078733A1 Quinazolines useful as modulators of ion channels |
| 09/16/2004 | WO2004078732A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
| 09/16/2004 | WO2004078731A1 Quinoline-carboxylic acids and the derivatives thereof, a focused library |
| 09/16/2004 | WO2004078729A1 Process for the production of substituted nicotinic acid esters |
| 09/16/2004 | WO2004078723A1 Novel compound having 4-pyridylalkylthio group as substituent |
| 09/16/2004 | WO2004078722A1 Organic compound and organic electroluminescence device |
| 09/16/2004 | WO2004078176A1 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators |
| 09/16/2004 | WO2004078128A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078116A2 P38 inhibitors and methods of use thereof |
| 09/16/2004 | WO2004078114A2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists. |
| 09/16/2004 | WO2004078103A2 G-lactam derivatives as prostaglandin agonists |
| 09/16/2004 | WO2004078101A2 Urea derivatives having vanilloid receptor antagonist activity |
| 09/16/2004 | WO2004071445A3 2-(aminomethyl)arylamide analgesics |
| 09/16/2004 | WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 09/16/2004 | WO2004062562A3 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 09/16/2004 | WO2004058176A3 Acyclic pyrazole compounds |
| 09/16/2004 | WO2004050653A3 Oxime ester photoinitiators with heteroaromatic groups |
| 09/16/2004 | WO2004046101A3 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 09/16/2004 | WO2004043389B1 Methods of treating cancer and related methods |
| 09/16/2004 | WO2004028459A3 Piperidine derivatives |
| 09/16/2004 | WO2004026264A3 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 09/16/2004 | WO2004019889A3 Inhibitors of post-amadori advanced glycation end products |
| 09/16/2004 | WO2004010943A3 Substituted benzanilides as modulators of the ccr5 receptor |
| 09/16/2004 | WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/16/2004 | US20040181062 Benzimidazole cyclooxygenase-2 inhibitor |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040180944 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |